TITLE

Start anywhere, ask questions and fail early

AUTHOR(S)
Arnold, Matthew
PUB. DATE
May 2010
SOURCE
Medical Marketing & Media;May2010, Vol. 45 Issue 5, p28
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article presents the insights of chief executive officers (CEOs) on the future of the pharmaceutical industry in the U.S.
ACCESSION #
51204161

 

Related Articles

  • Precious Mettle. Comer, Benjamin // Pharmaceutical Executive;Jul2011, Vol. 31 Issue 7, p28 

    The article highlights the role of Tony Coles as chief executive officer (CEO) at Onyx Pharmaceuticals Inc. in leading the company to greater heights in the U.S. It recounts how the condition of his son having a compromising mediastinal mass has influenced his craft in discovering new compounds,...

  • Health lobbyists seeking to rekindle their relationship with Republicans. Pecquet, Julian // Hill;10/13/2010, Vol. 17 Issue 112, p14 

    The article reports that U.S. healthcare groups, which supported the Democrats' overhaul bill, are trying to revive their relationship with the Republicans. It states that some pharmaceutical company chief executive officers (CEOs) have been convening with Republicans when they have made visits...

  • Changing places. Plagakis, Jim // Drug Topics;5/17/99, Vol. 143 Issue 9, p46 

    Presents views on the role of chief executive officers (CEO) in a pharmaceutical company. Importance of pharmacists; Concern of a CEO.

  • Who's who in pharmaceutical industry.  // Economic Review (05318955);Aug96, Vol. 27 Issue 8, p33 

    Profiles three prominent chief executives of pharmaceutical companies in Pakistan. Brookes Pharmaceutical Labs president A. Haseeb Khan; Glaxo Wellcome Pakistan managing director Nighat Parveen; Highnoon Laboratories Ltd. chief executive Jawaid Tariq Khan.

  • CLINIC ROUNDUP.  // BioWorld Today;12/16/2008, Vol. 19 Issue 243, p7 

    This section offers news briefs on the pharmaceutical industry in the U.S. A study has been published by Medimmune and SDI Innovations about a study on the variances of the respiratory syncytial virus season between major U.S. metropolitan areas. Lars Adlersson has resigned as chief executive...

  • Quintiles Names New CEO.  // Contract Pharma;May2012, Vol. 14 Issue 4, p113 

    The article offers news briefs related to the pharmaceutical industry in the U.S. in 2012. Quintiles has named Tom Pike as its chief executive officer (CEO). Theorem Clinical Research's Singapore office has appointed Nitin Jain as its vice president and general manager for the Asia-Pacific...

  • Newsmakers.  // Chain Drug Review;2/27/2012, Vol. 34 Issue 4, p41 

    The article announces several executive appointments in the pharmaceutical industry of the U.S. including Paul Fonteyne as president and chief executive officer (CEO) at Boehringer lngelheim USA Corp., John Johnson as president and CEO at Dendreon Corp., and Mark Trudeau as senior vice president...

  • Chain drug retailing's events of the year. Pinto, David // Chain Drug Review;11/23/2009, Vol. 31 Issue 20, p14 

    The article discusses some of the memorable events related to drugstores in the U.S. in 2009. It highlights the move of Walgreens Co. to remake its chain drug retailing business by adopting a new approach. It also notes the appointment of Greg Wasson as chief executive officer of Walgreens. The...

  • Pharmacy Outlook '12: The Biotechnology Industry Organization (BIO) James Greenwood, President and CEO. Greenwood, James // Chain Drug Review;1/2/2012, Vol. 34 Issue 1, p92 

    The article presents the views of James Greenwood, president and chief executive officer (CEO) of the Biotechnology Industry Organization (BIO), regarding the 2012 outlook for pharmaceutical industry in the U.S. He is critical on the Promise of Biotechnology initiative developed by BIO which...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics